Report of Foreign Issuer (6-k)
April 13 2018 - 11:52AM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
W
ashington,
D.C.
20549
FORM
6-K
Report
of Foreign Private Issuer
Pursuant
to Rule 13a-16 or 15d-16
of the
Securities Exchange Act of 1934
For
the month of April 2018
Commission
File Number: 001-37643
KITOV
PHARMA
LTD.
(Translation
of registrant's name into English)
One
Azrieli Center, Round Tower,
Tel
Aviv 6701101, Israel
(Address
of principal executive offices)
Indicate
by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.
Form
20-F ☒ Form 40-F ☐
Indicate
by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ____
Indicate
by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ____
On
April 13, 2018, Kitov Pharma Ltd. (the “Company” or the “Registrant”) issued a press release, “
TyrNovo
to Present at 2018 Annual Meeting of the American Association for Cancer Research
”, which is attached hereto as Exhibit
99.1
Attached
hereto are the following exhibits:
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf
by the undersigned, thereunto duly authorized.
|
KITOV
PHARMA LTD.
|
|
|
April
13, 2018
|
By:
|
/s/
Isaac Israel
|
|
|
Isaac Israel
|
|
|
CEO and Director
|
2
Kitov Pharma (NASDAQ:KTOV)
Historical Stock Chart
From Aug 2024 to Sep 2024
Kitov Pharma (NASDAQ:KTOV)
Historical Stock Chart
From Sep 2023 to Sep 2024